United Therapeutics Corporation revenue for the last year amounted to 2.33 B USD, the most of which — 2.33 B USD — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 1.94 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought United Therapeutics Corporation 2.20 B USD, and the year before that — 1.81 B USD.